☰
×
News
Top 20
Insights
Insights+
ThoughtSpot
Interviews
Viewpoints
Exclusive
Spotlight
Events
Magazine
Bespoke
Newswire
x
Search
Search here
Search here
Subscribe Now
PREVENT
Regeneron Reports Results of REGEN-COV Antibody Cocktail in P-III Trial to Prevent COVID-19
March 23, 2021
Regeneron Reports Results of REGEN-COV Antibody Cocktail Used as Passive Vaccine to Prevent COVID-19
January 27, 2021
Provention Bio Reports Submission of BLA and Priority Review to the US FDA for Teplizumab to Prevent T1D
January 4, 2021
Pfizer and BioNTech's BNT162b2 Receives the US FDA's EUA to Prevent COVID-19
December 14, 2020
Sanofi's Supemtek Receives CHMP's Positive Opinion for Approval to Prevent Influenza
September 23, 2020
Eli Lilly in Collaboration with NIAID Initiate P-III Study of LY-CoV555 to Prevent COVID-19
August 4, 2020
Load more...
Back to Home
Modal title
×
Modal body text goes here.